BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Systems Xcellence Inc. (SXC) Announces Record 2006 First Quarter Financial Results


5/4/2006 11:01:27 AM

MILTON, ON, May 4 /PRNewswire-FirstCall/ - Systems Xcellence Inc., ("SXC" or the "Company") a leading provider of healthcare information technology solutions throughout the pharmaceutical supply chain, announces financial results for the three-month period ended March 31, 2006. All figures are in U.S. dollars, unless otherwise noted.

Highlights for Q1: - Revenue increased 83% to $19.3 million from $10.6 million in Q1 fiscal 2005 - Transaction processing revenue, which is the primary driver of recurring revenue, increased 77% to $8.8 million from $5.0 million - Revenue from recurring sources increased 52% to $12.4 million from $8.2 million - Earnings before interest, taxes, depreciation and amortization (EBITDA) increased 343% to $5.8 million or 30% of revenue from $1.3 million, or 12% of revenue - Net income before tax increased to $3.7 million from $45,606. - Increased "Book of Business" to $140 million at March 31, 2006, up from $108 million at December 31, 2005 - Now supporting more than 1.6 million U.S. Medicare Part D pharmacy benefit program ("Part D") members on behalf of 11 InformedRx and claims processing customers.

"We are extremely pleased with our start to the new year," said Gordon S. Glenn President and CEO of SXC. "Q1 results exceeded our expectations due primarily to increased transaction processing revenue generated from both the Medicare Part D program and new customers that began processing on January 1, 2006. To a lesser extent, significant professional service and software license revenue from clients that are participating in the Part D program also contributed to this growth. So far, both the number of lives and the volume of transactions processed relative to Part D have surpassed our initial targets. We believe the contribution of revenue related to Part D will normalize somewhat throughout the remainder of the year, however, due to our strong start, we are revising our guidance upward."

Financial Review

Revenue for the three-month period ended March 31, 2006 was $19.3 million, up 83% compared to $10.6 million in the same period last year. Revenue of a recurring nature was $12.4 million during this period, up 52% compared to $8.2 million in the first quarter of 2005. Transaction processing revenue was $8.8 million in the first quarter, up 77% compared to $5.0 million in the same period of 2005.

Revenue from non-recurring sources was $6.9 million in Q1 compared to $2.4 million in the prior period, a 187.5% increase. Systems sales revenue (which includes both software and hardware license revenue) was $2.55 million in the current period, compared to $1.1 million in the prior period, a 132% increase. Professional service revenue was $4.4 million compared to $1.3 million in the prior period, a 238% increase. First quarter revenue growth was driven primarily to the increase in transaction processing volume along with consulting and implementation services performed for customers who are participating in the Part D program.

Gross margin for the first quarter was 61%, compared with 57% in the same period last year. The increase in gross margin is primarily due to the increase in higher margin transaction processing revenue and professional services revenue related to the launch of Part D.

Product development expenses on an absolute dollar basis were consistent at $2.1 million, or 11% of revenue, compared with $2.1 million, or 20% in the same period last year. Product development expenses decreased as a percentage of revenue due primarily to personnel resources being temporarily allocated to Part D professional services projects in Q1 2006.

SG&A expenses were $3.9 million, or 20% of revenue, compared with $2.6 million, or 24% of revenue in the same period last year. SG&A expenses rose on an absolute dollar basis as the Company invested in its sales capabilities and in bringing new products to market.

First quarter EBITDA was $5.8 million, or 30% of revenue, compared to $1.3 million, or 12% of revenue. The increase in EBITDA reflects the significant increase in revenue, an increase in higher margin transaction processing revenue and SXC's ongoing efforts at cost control.

Net income for the first quarter was $5.6 million, or $0.08 per share (fully diluted) compared with $15,606, or $0.00 per share, in the first quarter last year. Net income includes a $0.8 million lease termination charge for its facility in Illinois as the Company has entered into a lease for a new location. The new landlord has provided an offsetting $0.8 million lease inducement; however this inducement will be amortized over the term of the new lease. In addition net income includes a non-cash $1.9 million future tax recovery that was recognized based on the expected future profitability of SXC coupled with its tax loss carry forwards.

Liquidity and Resources

SXC continues to operate with a strong balance sheet from which to pursue its growth initiatives. At March 31, 2006, the company had a working capital position of $41.0 million, with cash and cash-equivalents of $36.9 million, compared with $37.3 million of working capital and $36 million of cash and cash-equivalents at March 31, 2005.

In the first quarter of 2006, SXC generated cash from operations of $1.8 million, an increase of 148% compared to $0.7 million generated in the first quarter last year.

2006 Financial Guidance

As a result of the strong start to 2006, the Company has revised its guidance upward and has established the following financial goals for fiscal 2006: consolidated revenue of $70-73 million, EBITDA of $17.5-19 million and earnings per share (fully-diluted) of $0.16-0.18.

In addition, for 2006, the Company expects to increase overall transaction processing levels by at least 96% to more than 275 million adjudicated and switched transactions. Approximately 41% of this growth, or 55 million transactions, is expected to result from the Part D program with the balance originating from the Company's commercial and State Medicaid initiatives.

EBITDA Reconciliation to Net Income

EBITDA (earnings before interest, taxes, depreciation and amortization) is a non-GAAP measure that management believes is a useful supplemental measure of operating performance prior to amortization, debt service and income tax. Investors are cautioned that EBITDA should not be construed as an alternative to net income determined in accordance with GAAP as an indicator of the Company's performance or to cash flows from operations as a measure of liquidity and cash flows. EBITDA does not have a standardized meaning prescribed by GAAP. The Company's method of calculating EBITDA may differ from the methods used by other companies and, accordingly, it may not be comparable to similarly titled measures used by other companies. Reconciliation of EBITDA to net income is shown below:

For the three months ended -------------------------- 31-Mar-06 31-Mar-05 -------------- -------------- EBITDA $ 5,757,708 $ 1,301,170 Amortization (896,625) (775,388) Stock-based Compensation (478,857) (138,537) Lease Termination (757,815) - Interest expense, net 93,323 (353,976) Income Taxes 1,858,798 (30,000) -------------- -------------- Income (loss) after taxes $ 5,576,532 $ 15,606 -------------- -------------- -------------- -------------- Notice of Conference Call

SXC will host a conference call on May 4, 2006 at 8:30AM (ET) to discuss its first quarter financial results. Mr. Gordon S. Glenn, President and CEO, will host the call. To participate on the call, please dial 416-644-3429 or 1-800-814-4857.

A replay of the call can be heard by dialling 1-877-289-8525 or 416-640-1917 and entering the reference code 21185972. The taped call is available until May 11, 2006.

A live audio webcast of the call will be available at www.sxc.com and www.newswire.ca. Webcast attendees are welcome to listen to the conference in real-time or on-demand at your convenience.

About Systems Xcellence

Systems Xcellence (SXC) is headquartered in Milton, Ontario with offices and processing centres in Lombard, Illinois, Scottsdale, Arizona, Warminster, Pennsylvania and Victoria, British Columbia. SXC is a leading provider of healthcare information technology solutions and services to the healthcare benefits management industry. The company's product offerings and solutions combine a wide range of software applications, application service provider (ASP) processing services and professional services, designed for many of the largest organizations in the pharmaceutical supply chain, such as pharmacy benefit managers, managed care organizations, retail pharmacy chains and other healthcare intermediaries. SXC can be found on the Internet at www.sxc.com.

This press release contains forward-looking statements based on current expectations. These forward-looking statements entail various risks and uncertainties that could cause actual results to differ materially from those reflected in these forward-looking statements. Risks and uncertainties about the Company's business are more fully discussed in the Company's Annual Information Form.

SYSTEMS XCELLENCE INC. Consolidated Balance Sheets March 31, December 31, 2006 2005 (All amounts are in US dollars) (unaudited) ------------------------------------------------------------------------- ASSETS Current assets: Cash and cash equivalents $ 36,853,736 $ 35,951,932 Accounts receivable 13,550,433 8,649,801 Unbilled revenue 1,243,103 1,001,971 Prepaid expenses 1,117,518 1,191,444 Inventory 423,553 437,674 Future tax asset 806,805 320,000 ------------------------------------------------------------------------- 53,995,148 47,552,822 Capital assets 4,663,713 3,777,954 Deferred charges 740,674 787,686 Goodwill and other intangible assets 26,427,711 26,825,147 Future tax asset 2,410,000 360,000 Other assets 2,000,000 2,000,000 ------------------------------------------------------------------------- $ 90,237,246 $ 81,303,609 ------------------------------------------------------------------------- ------------------------------------------------------------------------- LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable and accrued liabilities $ 7,434,036 $ 5,598,912 Deferred revenue 3,661,248 3,131,031 Current portion of long-term debt 1,700,000 1,530,000 ----------------------------------------------------------------------- 12,795,284 10,259,943 Long-term debt 11,075,953 11,572,858 Deferred leasehold inducement 757,815 - Shareholders' equity: Capital stock 64,129,217 64,047,220 Contributed surplus 2,197,229 1,718,372 Deficit (718,252) (6,294,784) ----------------------------------------------------------------------- 65,608,194 59,470,808 ------------------------------------------------------------------------- $ 90,237,246 $ 81,303,609 ------------------------------------------------------------------------- ------------------------------------------------------------------------- SYSTEMS XCELLENCE INC. Consolidated Statements of Operations (unaudited) Three Months Three Months ended ended (All amounts are in US dollars) March 31, 2006 March 31, 2005 ------------------------------------------------------------------------- Revenue $ 19,337,153 $ 10,572,667 Project costs 7,605,479 4,519,916 ------------------------------------------------------------------------- 11,731,674 6,052,751 Expenses: Product development costs 2,105,361 2,161,309 Selling, general and administration 3,868,605 2,577,935 Amortization 896,625 775,388 Lease termination 757,815 - Stock-based compensation 478,857 138,537 ----------------------------------------------------------------------- 8,107,263 5,653,169 ------------------------------------------------------------------------- Income before the undernoted 3,624,411 399,582 Net interest: Income (483,801) (72,106) Expense 390,478 426,082 ----------------------------------------------------------------------- (93,323) 353,976 Income before income taxes 3,717,734 45,606 Income tax expense (recovery) : Current 678,007 30,000 Future (2,536,805) - ----------------------------------------------------------------------- (1,858,798) 30,000 Net income $ 5,576,532 $ 15,606 ------------------------------------------------------------------------- ------------------------------------------------------------------------- Net income per share: Basic $ 0.08 $ 0.00 Diluted $ 0.08 $ 0.00 Weighted average number of shares used in computing net income per share: Basic 67,804,330 58,334,867 Diluted 72,148,240 60,441,866 Consolidated Statements of Deficit (unaudited) Three Months Three Months ended ended March 31, 2006 March 31, 2005 ------------------------------------------------------------------------- Deficit, beginning of period $ (6,294,784) $ (14,016,920) Net income 5,576,532 15,606 ------------------------------------------------------------------------- Deficit, end of period $ (718,252) $ (14,001,314) ------------------------------------------------------------------------- ------------------------------------------------------------------------- SYSTEMS XCELLENCE INC. Consolidated Statements of Cash Flows (unaudited) Three Months Three Months ended ended (All amounts are in US dollars) March 31, 2006 March 31, 2005 ------------------------------------------------------------------------- Cash provided by (used in): Operations: Net income $ 5,576,532 $ 15,606 Items not involving cash, net of effects from acquisition: Amortization of capital assets 499,189 396,223 Amortization of intangible assets 397,436 332,500 Amortization of deferred charges 47,012 46,665 Stock-based compensation 478,857 138,537 Future tax asset (2,536,805) - Changes in non-cash operating working capital (2,688,372) (213,711) ----------------------------------------------------------------------- Net cash provided by operations 1,773,849 715,820 Financing: Proceeds from exercise of share-purchase options 81,997 6,160 Repayment of short-term liabilities - (18,000,000) Increase in deferred leasehold inducements 757,815 - Financing costs related to long-term liabilities - 50,000 Repayment of long-term liabilities (326,905) (12,939) ----------------------------------------------------------------------- Net cash used in financing 512,907 (17,956,779) Investing: Purchase of capital assets (1,384,952) (247,572) ----------------------------------------------------------------------- Cash used in investments (1,384,952) (247,572) ------------------------------------------------------------------------- Increase (decrease) in cash and cash equivalents 901,804 (17,488,531) Cash and cash equivalents, beginning of period 35,951,932 29,636,643 ------------------------------------------------------------------------- ------------------------------------------------------------------------- Cash and cash equivalents, end of period $ 36,853,736 $ 12,148,112 ------------------------------------------------------------------------- -------------------------------------------------------------------------

Systems Xcellence

CONTACT: Dave Mason, Investor Relations - Canada, The Equicom Group Inc.,(416) 815-0700 ext. 237, dmason@equicomgroup.com; Jeff Park, ChiefFinancial Officer, Systems Xcellence Inc., Tel: (905) 876-4741,investors@sxc.com OR Susan Noonan, Investor Relations - U.S., The SANGroup, LLC, (212) 966-3650, susan@sanoonan.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES